#JITC: Therapy with high-dose Interleukin-2 (HD IL-2) in metastatic melanoma and renal cell carcinoma following PD1 or PDL1 inhibition jitc.biomedcentral.com/articles/10.11… #Melanoma

A new #clinicaltrial at Providence Oregon will study the effectiveness of checkpoint #immunotherapy combined with an investigational cytokine agent in patients with advanced #renal cancer, compared to standard of care targeted therapy. Learn more. > ow.ly/BHb050vqe8a Photo: NIH

29 billion neoantigen selected T cell for adoptive transfer to treat a pancreatic CA pt made in Dr. Tran’s lab at EACRI. Cutting edge cancer research at #EACRI #finishcancer #providencecancerinstitute

Dr. Eric Tran Chiles Research Institute Providence Oregon presents his approach to assessing neoantigen specific T cell responses in the blood and harnessing them for adoptive T cell therapy. Big milestone to be announced soon-stay tuned! #NewHorizons2019 Surgery Branch

As @HTCRelay Title Sponsor, we are excited to field nine teams made up of Providence caregivers from across Oregon, researchers, clinicians, cancer survivors and patients to #HTC19 and #PTC19! We’ll see you at the start line soon!

#TBT by ASTRO It's wonderful to have Marka Crittenden, MD, PhD, from Chiles Research Institute and Salma Jabbour, MD (Salma Jabbour) from Rutgers Cancer Institute to stop by the ASTRO office on #WomenWhoCurie Day! Thank you both for all that you do! #RadOncWomen #WomenInMedicine

Hey #SITC19-Chiles Research Institute Providence Oregon @psjh has #immunooncology FELLOWSHIP for #medonc, #radonc #surgonc: work w gurus Bernard A Fox Walter J Urba MD, PhD Dr. Brendan Curti Rom Leidner @davidbpage Andrew Weinberg William Redmond Eric Tran, Marka Crittenden, Michael Gough, more-reply w interest

We seek candidates for 3-year I-O #postdoc fellowship in beautiful #Portland OR! Join our team of world-renowned investigators working in T-cell based #immunotherapy. Ideal for recent PhD/MDPhD grads w/ training in T cell biology. Learn more> qrco.de/bbJhCt #sciencejobs

One of many cutting edge trials we have for our patients at Providence Cancer Institute.#finishcancer

We are excited to welcome Dr Matthew Taylor to our #FinishCancer team! Dr Taylor leads our new Developmental Cancer Therapeutics Lab, where his team studies immune evasion and biomarkers of therapeutic response to #immunotherapy. Learn more. > ow.ly/D3Wi50xFv9P

Evergreen from ⁦JAMA Oncology⁩: “Using the battle metaphor implies that if a patient fights hard enough, smart enough, and/or long enough, he or she will be able to win the war.” This is simply not true for some & I’ll be damned to imply they are losers jamanetwork.com/journals/jamao…

Today makes 11 years NED from a terminal cancer DX. #immunotherapy Providence Oregon Chiles Research Institute Don't. Stop. Believin. #supportcancerresearch #finishcancer

Providence Cancer Institute invited 30 students for a lab tour to kick off the The Leukemia & Lymphoma Society Student of the Year campaign, a philanthropic development program where local high school leaders build professional skills as they prepare for college. #FINISHCANCER ow.ly/87VW50y3sFB

Welcome Dr Sasha Stanton to our #FINISHCANCER team! A physician scientist with expertise in #breastcancer, Dr Stanton has extensive training in #moleculargenetics & #immunotherapy. Learn about her translational research. > ow.ly/xqeH50y68WB

Join us as we celebrate #WomenInScienceDay and thank some of our own leaders in science Chiles Research Institute: Alison conlin, Dr Kristina Young and Dr Marka Crittenden. #WomeninSTEM #WomenInScience #FinishCancer

We are the only center on the West Coast to offer two new early phase studies to investigate the activity of combination #immunotherapy in #mucosalmelanoma and other high-risk skin cancers. To learn more or refer patients to these studies >> ow.ly/VZpx50yANvy #FinishCancer

2629 Italian drs been infected w/ #COVID19 #coronavirus, & 13 have died, incl some who left retirement to help. In total, 8.3% of all cases have been in HCW. Please prioritize more masks, gloves, & other supplies! #GetMePPE bit.ly/2QAdd3D cc Nancy Pelosi @senatemajldr

Proud to announce our team, led by Bernard A Fox and Rom Leidner in partnership with OncoSec Medical, to harness our #immunotherapy expertise in testing #vaccine against #COVID19. ow.ly/BaRx50z1buv

Read the latest from Journal for ImmunoTherapy of Cancer on our pilot study led by Dr. Brendan Curti and team which found SBRT + IL-2 induced more objective responses with a higher DCR compared to IL-2 monotherapy in metastatic #melanoma. #FinishCancer Lyn Dobrunick Walter J Urba MD, PhD